1. SARS-CoV-2 and rhinovirus infections: are there differences in clinical presentation, laboratory abnormalities, and outcomes in the pediatric population?
- Author
-
Pereira MFB, Suguita P, Litvinov N, Farhat SCL, Paula CSY, Lázari CDS, Bedê PV, Framil JVS, Bueno C, Branas PCAA, Guimarães IMDC, Leite MM, Navega ACB, Nanbu DY, Schvartsman C, Pinho JRR, Silva CAA, Marques HHS, Eisencraft AP, Rossi A Jr, Delgado AF, Leal GN, Gibelli MAC, Palmeira P, Sakita NK, Santos EHD, Rocha MC, Kanunfre KA, Okay TS, Carneiro-Sampaio M, and Carvalho WB
- Subjects
- Adolescent, Child, Humans, Rhinovirus, SARS-CoV-2, COVID-19 diagnosis, Communicable Diseases
- Abstract
This study aims to assess COVID-19 and other respiratory viruses in pediatric patients. Between April 17 and September 30, 2020, we collected 1,566 respiratory samples from 1,044 symptomatic patients who were younger than 18 years old to assess SARS-CoV-2 infection. Of these, 919 were analyzed for other respiratory pathogens (ORP). Patients with laboratory-confirmed COVID-19 or ORP were included. We evaluated 76 pediatric COVID-19 infections and 157 other respiratory virus infections. Rhinovirus occurred in 132/157 (84%). COVID-19 patients who were significantly older, had more fevers, headaches and pneumonia than those with ORP. The median white blood cell count was lower in patients with SARS-CoV-2 than in those with ORP (6,470 versus 8,170; p=0.02). COVID-19 patients had significantly worse symptoms than those with ORP.
- Published
- 2022
- Full Text
- View/download PDF